A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909)-Reference-Cited by-同舟云学术

A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909)

Published:2021-01 Issue:1 Volume:9 Page:73-73
ISSN:2305-5839
Container-title:Annals of Translational Medicine
language:
Short-container-title:Ann Transl Med

Author:

Zheng Yan, ,Liu Xian-Ben,Sun Hai-Bo,Xu Jinliang,Shen Sining,Ba Yu-Feng,Yan Ming,Qin Zimin,Liu Bao-Xing,Wang Zong-Fei,Liu Shi-Lei,Zhang Rui-Xiang,Chen Pei-Nan,Liang Guang-Hui,Yuan Dongfeng,Li Zhen-Xuan,Liu Qi,Wang Hao-Ran,Li Hao-Miao,Lv Hongwei,Ma Xiaochao,Zhu Jianping,Yu Yong-Kui,Xing Wen-Qun

Publisher

AME Publishing Company

Subject

General Medicine

Link

https://atm.amegroups.com/article/download/59255/pdf

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial;Cancer Communications;2024-09-02

2. Neoadjuvant Sintilimab Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Real-World Study;2024-07-04

3. Immunotherapy in the neoadjuvant treatment of gastrointestinal tumors: is the time ripe?;Journal for ImmunoTherapy of Cancer;2024-05

4. Does microbiota composition act as predictive signature for the evaluation of chemoimmunotherapy response efficacy?;Journal of Gastrointestinal Oncology;2024-02

5. Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma;Technology in Cancer Research & Treatment;2024-01